Verified earnings results
Metagenomi Therapeutics Q3 2026 Earnings Results
Direct answer
Metagenomi Therapeutics reported Q3 2026 results on November 10, 2026.
Revenue was 2,184,000. EPS beat the estimate by 13.31%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Metagenomi Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- November 10, 2026
- Reported timing
- After the US market closes
- EPS estimate
- -0.646
- Reported EPS
- -0.56
- Revenue
- 2,184,000
- EPS surprise
- EPS beat the estimate by 13.31%.
Explore related company data
Read the frequently asked questions.
When did Metagenomi Therapeutics report Q3 2026 earnings?
Metagenomi Therapeutics reported on November 10, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for Metagenomi Therapeutics?
The verified record provides an EPS estimate of -0.646.
Has Metagenomi Therapeutics reported the Q3 2026 result?
Revenue was 2,184,000. EPS beat the estimate by 13.31%.
Which source supports this Metagenomi Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.